Marblegate Capital (MGTE) EBITDA Margin (2024 - 2026)
Marblegate Capital's (MGTE) quarterly EBITDA Margin came in at 4.33% in Q4 2025, down 2617.0% YoY from 0.17% in Q4 2024, and up 58.25% on a QoQ basis from 10.37% in Q3 2025.
Marblegate Capital (MGTE) EBITDA Margin (2024 - 2026) Analysis & Trends
Marblegate Capital (MGTE) has 2 years of EBITDA Margin data on file, last reported at 4.33% in Q4 2025.
- Quarterly EBITDA Margin fell 2617.0% year-over-year to 4.33% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 3.54% (down 2300.0% YoY) and the FY2025 annual result came in at 1.67%, down 2730.0% from the prior year.
- EBITDA Margin advanced to 4.33% in Q4 2025, from 10.37% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 33.95% in Q3 2024 to a low of 10.37% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | - |
| 2 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | - |
| 3 | Cantor Equity Partners IV | 467.55 Mn | 467.55 Mn | - | - |
| 4 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | - |
| 5 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | - |
| 6 | Gores Holdings X | 381.05 Mn | 380.85 Mn | - | - |
| 7 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | - |
| 8 | Blue Water Acquisition Corp. III | 342.12 Mn | 342.08 Mn | - | - |
| 9 | Berto Acquisition | 313.96 Mn | 313.81 Mn | - | - |
| 10 | Marblegate Capital | 87.22 Mn | 180.32 Mn | - | -25.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.77% |
| Dec 31, 2025 | -4.33% |
| Sep 30, 2025 | -10.37% |
| Jun 30, 2025 | 20.03% |
| Mar 31, 2025 | -6.42% |
| Dec 31, 2024 | 21.84% |
| Sep 30, 2024 | 33.95% |
| Jun 30, 2024 | 23.36% |